Drug Name : Zidovudine
Indication :Zidovudine is the first approved drug for the treatment of HIV infection. The drug is a competitive inhibitor of HIV reverse transcriptase, which disrupts viral replication because the DNA can no longer elongate.
Normal Values :Not established
Critical Values :Not established
Test Method :High performance liquid chromatography (HPLC), Radio Immunoassay (RIA)
Side effects :hematologic suppression - anemia, leukopenia, granulocytopenia. Hepatic and renal failure.